Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.